Marinos Tsiatas

Author PubWeight™ 7.72^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2.	Int J Cancer	2011	1.05
2	Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?	Obstet Gynecol Int	2010	0.97
3	Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy.	J Transl Med	2011	0.96
4	Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer.	Urology	2011	0.91
5	Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress.	Atherosclerosis	2010	0.87
6	Where do cancer patients die in Greece? A population-based study on the place of death in 1993 and 2003.	J Pain Symptom Manage	2009	0.82
7	Phenoxodiol, an anticancer isoflavene, induces immunomodulatory effects in vitro and in vivo.	J Cell Mol Med	2009	0.80
8	Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.	Anticancer Res	2006	0.78
9	Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology.	Int J Nanomedicine	2007	0.78
10	Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain.	J Opioid Manag	2007	0.75
11	The incidence of place of death in Greek patients with cancer in 1995 and 2005.	Am J Hosp Palliat Care	2009	0.75
12	Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study.	Pharmacogenomics	2012	0.75